By focusing on cognitively unimpaired individuals, i.e., those in the earliest stages of tau propagation, this study points to characteristics that could help identify which individuals are at greatest risk of progression to AD and could therefore benefit the most from pathology‐lowering interventions. The gene discussed is MAPT; the disease is Alzheimer disease.